MassBio's Luba Greenwood also discusses her decision to leave Verily in order to pursue teaching the intersection of life science and technology at Harvard. Global Innovation Pulse By Laura Lovett | July 26, 2019 | 6:52 PM Topic: Innovation Pulse, Women In Health IT, Workflow